References
- Halladin NL, Zahle FV, Rosenberg J, et al. Interventions to reduce tourniquet-related ischaemic damage in orthopaedic surgery: a qualitative systematic review of randomised trials. Anaesthesia. 2014;69(9):1033–1050.
- Wigmore T, Gottumukkala V, Riedel B. Making the case for the subspecialty of onco-anesthesia. Int Anesthesiol Clin. 2016;54(4):19–28.
- Yassin MM, Harkin DW, Barros D’Sa AA, et al. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002;26(1):115–121.
- Kohl BA, Deutschman CS. The inflammatory response to surgery and trauma. Curr Opin Crit Care. 2006;12(4):325–332.
- Torrance HD, Pearse RM, O'Dwyer MJ. Does major surgery induce immune suppression and increase the risk of postoperative infection? Curr Opin Anaesthesiol. 2016;29(3):376–383.
- Mokart D, Leone M, Sannini A, et al. Predictive perioperative factors for developing severe sepsis after major surgery. Br J Anaesth. 2005;95(6):776–781.
- Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581–2590.
- Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491–1501.
- Tasoulis MK, Douzinas EE. Hypoxemic reperfusion of ischemic states: an alternative approach for the attenuation of oxidative stress mediated reperfusion injury. J Biomed Sci. 2016;23:7.
- Xu Q, Li X, Lu Y, et al. Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/reperfusion. Br J Pharmacol. 2015;172(12):3072–3085.
- Pac-Soo CK, Mathew H, Ma D. Ischaemic conditioning strategies reduce ischaemia/reperfusion-induced organ injury. Br J Anaesth. 2015;114(2):204–216.
- Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol. 2006;72(11):1493–1505.
- Sakamoto H, Corcoran TB, Laffey JG, et al. Isoprostanes – markers of ischaemia reperfusion injury. Eur J Anaesthesiol. 2002;19(8):550–559.
- Morrow JD. The isoprostanes – unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm Des. 2006;12(8):895–902.
- Ting HJ, Khasawneh FT. Platelet function and isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family? J Biomed Sci. 2010;17(1):24.
- Janssen LJ. Isoprostanes and lung vascular pathology. Am J Respir Cell Mol Biol. 2008;39(4):383–389.
- Fessel JP, Porter NA, Moore KP, et al. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci U S A. 2002;99(26):16713–16718.
- Orr SK, Colas RA, Dalli J, et al. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. Am J Physiol Lung Cell Mol Physiol. 2015;308(9):L904–L911.
- Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101.
- Safavynia SA, Goldstein PA. The role of neuroinflammation in postoperative cognitive dysfunction: moving from hypothesis to treatment. Front Psychiatry. 2018;9:752.
- Wang X, Zhu M, Hjorth E, et al. Resolution of inflammation is altered in Alzheimer’s disease. Alzheimers Dement. 2015;11(1):40–50.e1-2.
- Zwemer CF, Shoemaker JL Jr., Hazard SW 3rd, et al. Hyperoxic reperfusion exacerbates postischemic renal dysfunction. Surgery. 2000;128(5):815–821.
- Chabot F, Mitchell JA, Gutteridge JM, et al. Reactive oxygen species in acute lung injury. Eur Respir J. 1998;11(3):745–757.
- Kaneda T, Ku K, Inoue T, et al. Postischemic reperfusion injury can be attenuated by oxygen tension control. Jpn Circ J. 2001;65(3):213–218.
- Corcoran TB, Barden AE, Mas E, et al. Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery. Free Radic Biol Med. 2011;51(6):1235–1239.
- Mas E, Barden AE, Corcoran TB, et al. Effects of spinal or general anesthesia on F2-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery. Free Radic Biol Med. 2011;50(9):1171–1176.
- Corcoran T, Ting S, Mas E, et al. Hyperbaric oxygen therapy is not associated with oxidative stress assessed using plasma F2-isoprostanes and isofurans. Prostaglandins Leukot Essent Fatty Acids. 2017;127:16–19.
- Barden A, Mas E, Croft KD, et al. Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation. J Lipid Res. 2014;55(11):2401–2407.
- Chu DK, Kim LHY, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018;391(10131):1693–1705.
- Mattishent K, Thavarajah M, Sinha A, et al. Safety of 80% vs 30–35% fraction of inspired oxygen in patients undergoing surgery: a systematic review and meta-analysis. Br J Anaesth. 2019;122(3):311–324.
- Halladin NL, Ekelof S, Alamili M, et al. Lower limb ischaemia and reperfusion injury in healthy volunteers measured by oxidative and inflammatory biomarkers. Perfusion. 2015;30(1):64–70.
- Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev. 1999;57(4):104–113.
- Halliwell B, Lee CYJ. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signal. 2010;13(2):145–156.
- Matte A, Recchiuti A, Federti E, et al. Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. Blood. 2019;133(3):252–265.
- Zhang LY, Jia MR, Sun T. The roles of special proresolving mediators in pain relief. Rev Neurosci. 2018;29(6):645–660.
- Barden AE, Moghaddami M, Mas E, et al. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins Leukot Essent Fatty Acids. 2016;107:24–29.